Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

Ciphergen Biosystems Inc.

Facebook Twitter LinkedIn Email Comments
Ciphergen Biosystems Inc. of Fremont and Bio-Rad Laboratories Inc. of Hercules, both in Calif., have signed an agreement in which the latter will acquire the former’s proteomics instrument business — including its surface-enhanced laser desorption/ionization technology — for approximately $20 million in cash. Bio-Rad will manufacture, sell and market the technology for proteomics applications and will supply Ciphergen with instruments for diagnostics business development. Ciphergen will retain exclusive rights to the diagnostics market. Bio-Rad also has made a $3 million equity investment in Ciphergen.

BioPhotonics
Sep 2006
BiophotonicsBusinessRapidScan

Comments
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.